TY - JOUR
T1 - cellSTAAR
T2 - incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of noncoding regions
AU - NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
AU - Van Buren, Eric
AU - Zhang, Yi
AU - Li, Xihao
AU - Selvaraj, Margaret Sunitha
AU - Li, Zilin
AU - Zhou, Hufeng
AU - Palmer, Nicholette D.
AU - Arnett, Donna K.
AU - Blangero, John
AU - Boerwinkle, Eric
AU - Cade, Brian E.
AU - Carlson, Jenna C.
AU - Carson, April P.
AU - Chen, Yii Der Ida
AU - Curran, Joanne
AU - Duggirala, Ravindranath
AU - Fornage, Myriam
AU - Franceschini, Nora
AU - Graff, Misa
AU - Gu, Charles
AU - Guo, Xiuqing
AU - He, Jiang
AU - Heard-Cosa, Nancy
AU - Hou, Lifang
AU - Hung, Yi Jen
AU - Kalyani, Rita R.
AU - Kardia, Sharon L.R.
AU - Kenny, Eimear
AU - Kooperberg, Charles
AU - Kral, Brian G.
AU - Lange, Leslie
AU - Levy, Dan
AU - Li, Changwei
AU - Liu, Simin
AU - Lloyd-Jones, Donald
AU - Loos, Ruth J.F.
AU - Manichaikul, Ani W.
AU - Martin, Lisa Warsinger
AU - Mathias, Rasika
AU - Minster, Ryan L.
AU - Mitchell, Braxton D.
AU - Mychaleckyj, Josyf C.
AU - Naseri, Take
AU - North, Kari
AU - O’Connell, Jeff
AU - Vasan, Ramachandran S.
AU - Mahaney, Michael
AU - Goring, Harald
AU - Glahn, David
AU - Almasy, Laura
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2025.
PY - 2026/2
Y1 - 2026/2
N2 - Understanding how rare genetic variants influence complex traits remains a major challenge, particularly when these variants lie in noncoding regions of the genome. The effects of variants within candidate cis-regulatory elements (cCREs) often depend on the cell type, making interpretation difficult. Here we introduce cellSTAAR, which integrates whole-genome sequencing data with single-cell assay for transposase-accessible chromatin using sequencing data to capture variability in chromatin accessibility across cell types via the construction of cell-type-specific functional annotations and regulatory elements. To reflect the uncertainty in cCRE–gene linking, cellSTAAR uses a comprehensive strategy to link cCREs to their target genes. We applied cellSTAAR to data from the Trans-Omics for Precision Medicine consortium (n ≈ 60,000) and replicated our findings using the UK Biobank (n ≈ 190,000). Across four lipid traits, cellSTAAR improved the detection of biologically meaningful associations and enhanced biological interpretability. These results demonstrate the potential of cell-type-aware approaches to boost discovery in rare variant whole-genome sequencing association studies.
AB - Understanding how rare genetic variants influence complex traits remains a major challenge, particularly when these variants lie in noncoding regions of the genome. The effects of variants within candidate cis-regulatory elements (cCREs) often depend on the cell type, making interpretation difficult. Here we introduce cellSTAAR, which integrates whole-genome sequencing data with single-cell assay for transposase-accessible chromatin using sequencing data to capture variability in chromatin accessibility across cell types via the construction of cell-type-specific functional annotations and regulatory elements. To reflect the uncertainty in cCRE–gene linking, cellSTAAR uses a comprehensive strategy to link cCREs to their target genes. We applied cellSTAAR to data from the Trans-Omics for Precision Medicine consortium (n ≈ 60,000) and replicated our findings using the UK Biobank (n ≈ 190,000). Across four lipid traits, cellSTAAR improved the detection of biologically meaningful associations and enhanced biological interpretability. These results demonstrate the potential of cell-type-aware approaches to boost discovery in rare variant whole-genome sequencing association studies.
UR - https://www.scopus.com/pages/publications/105027787046
UR - https://www.scopus.com/pages/publications/105027787046#tab=citedBy
U2 - 10.1038/s41592-025-02919-5
DO - 10.1038/s41592-025-02919-5
M3 - Article
C2 - 41476111
AN - SCOPUS:105027787046
SN - 1548-7091
VL - 23
SP - 338
EP - 349
JO - Nature Methods
JF - Nature Methods
IS - 2
ER -